Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
about
Emerging role of S-1 in gastric cancerPotential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational studyEfficacy of docetaxel combined with oxaliplatin and fluorouracil against stage III/IV gastric cancer.Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy.Laparoscopy-assisted gastrectomy with para-aortic lymphadenectomy after palliative chemotherapy for advanced gastric cancer with isolated para-aortic lymph node metastasisEfficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancer.Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial.Preoperative Chemotherapy for Gastric Cancer: Personal Interventions and Precision Medicine.Clinical efficacy of neoadjuvant chemotherapy regimens FLEEOX vs. XELOX in patients with initially unresectable advanced gastric cancer: a propensity score analysis.Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy.The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase IValidity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer.Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer.RPN2 is effective biomarker to predict the outcome of combined chemotherapy docetaxel and cisplatin for advanced gastric cancer.
P2860
Q26774720-CF8F44A9-4FD8-49FB-9B5A-58C8063930C7Q33612711-53C12BEE-0B8B-43C8-A461-4A0E8D462C38Q34779242-18DE19DC-144B-48DB-B409-939180D75E9DQ35060024-6706F521-B29B-414E-B6C3-DDFCD8A25302Q36809632-029204BA-3A70-46CF-ADB1-5F4C4C033CFDQ36897944-10045A65-8CAF-41EC-93B1-722AB77FEBBCQ38264664-B10977CF-6188-4C60-B6AC-00929B28697BQ38377462-33DBB44E-97EA-460F-A02B-F7CD8C03980BQ42332601-D2865085-F253-4472-A419-98506CA53E98Q43791962-2400E219-1D0F-4D57-97C2-E3C87702BAA8Q46019834-8C39BB8F-9A2D-4B7D-9A18-5C9451E441C6Q47096384-8881E51B-9EAD-4A99-B352-45ABCF26E88EQ47322506-41A0ED58-BDEF-415D-8A54-5302F2B1CC9DQ53490905-A72AF170-C82D-4CDE-A72E-F9D58D82BA52Q55551032-552779B7-30E8-4852-90E9-F02B3E025091
P2860
Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Efficacy of pre-operative chem ...... itive para-aortic lymph nodes.
@en
Efficacy of pre-operative chem ...... itive para-aortic lymph nodes.
@nl
type
label
Efficacy of pre-operative chem ...... itive para-aortic lymph nodes.
@en
Efficacy of pre-operative chem ...... itive para-aortic lymph nodes.
@nl
prefLabel
Efficacy of pre-operative chem ...... itive para-aortic lymph nodes.
@en
Efficacy of pre-operative chem ...... itive para-aortic lymph nodes.
@nl
P2093
P2860
P356
P1476
Efficacy of pre-operative chem ...... itive para-aortic lymph nodes.
@en
P2093
Hidehiro Tajima
Hideto Fujita
Hirohisa Kitagawa
Hironori Hayashi
Hiroyuki Takamura
Hisatoshi Nakagawara
Isamu Makino
Itasu Ninomiya
Jun Kinoshita
Katsunobu Oyama
P2860
P304
P356
10.1002/JSO.22125
P577
2011-10-17T00:00:00Z